About the Authors
- Lawrence J. Druhan
-
Affiliation The Department of Hematologic Oncology, The Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, United States of America
- Amanda Lance
-
Affiliation The Department of Hematologic Oncology, The Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, United States of America
- Shimena Li
-
Affiliation The University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America
- Andrea E. Price
-
Affiliation The Department of Hematologic Oncology, The Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, United States of America
- Jacob T. Emerson
-
Affiliation The Department of Hematologic Oncology, The Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, United States of America
- Sarah A. Baxter
-
Affiliation The Department of Hematologic Oncology, The Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, United States of America
- Jonathan M. Gerber
-
Affiliation The Department of Hematologic Oncology, The Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, United States of America
- Belinda R. Avalos
-
* E-mail: belinda.avalos@carolinashealthcare.org
Affiliation The Department of Hematologic Oncology, The Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceptualization: BRA LJD. Formal analysis: LJD AL. Funding acquisition: BRA LJD SL. Investigation: SL AL AEP JTE SAB. Methodology: BRA LJD AEP. Project administration: BRA LJD. Resources: BRA. Supervision: BRA LJD. Validation: LJD AL AEP. Visualization: LJD SL AL AEP. Writing – original draft: BRA LJD. Writing – review & editing: BRA LJD JMG.